Jacobs John C 4
4 · NOVAVAX INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2026-03-03+150,167→ 264,130 total - Tax Payment
Common Stock
[F1]2026-03-03$9.49/sh−69,288$657,543→ 225,680 total - Exercise/Conversion
Restricted Stock Units
[F2]2026-03-03−150,167→ 300,333 totalExercise: $0.00Exp: 2035-03-03→ Common Stock (150,167 underlying)
Footnotes (2)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.
Signature
/s/ Mark J. Casey, Attorney-in-Fact|2026-03-05